<html>
<head>
<meta content="text/html; charset=ISO-8859-1"
http-equiv="Content-Type">
</head>
<body bgcolor="#FFFFFF" text="#000000">
<br>
<div class="moz-cite-prefix">Am 01.02.13 22:59, schrieb Peter
Murray-Rust:<br>
</div>
<blockquote
cite="mid:CAD2k14PreqGktsp=5kwhRewnR7NfPBNuGs-9P2OWO6k-nbzMpg@mail.gmail.com"
type="cite">But publishers need to prevent innovation from people
like me as it threatens their "ownership of content".
</blockquote>
...<br>
<blockquote
cite="mid:CAD2k14PreqGktsp=5kwhRewnR7NfPBNuGs-9P2OWO6k-nbzMpg@mail.gmail.com"
type="cite">And the product will be an order of magnitude more
valuable than any current closed scientific databases. The results
will be fully semantic with recall/precision perhaps 50%.</blockquote>
I can't wait to see it! And indeed, Google started with two people
having a good idea and not even a garage. <br>
Prevailing legal practises in academic publishing are designed to
prevent similar success from happening.<br>
<br>
<div class="moz-cite-prefix">Am 02.02.13 02:02, schrieb Arthur Sale:<br>
</div>
<blockquote
cite="mid:000f01ce00e0$ed869ea0$c893dbe0$@ozemail.com.au"
type="cite">
<p class="MsoNormal"><span
style="font-family:"Calibri","sans-serif";color:#1F497D">I
have called it the Titanium Road to emphasise that it is based
on social networking rather than mandates</span></p>
</blockquote>
ResearchGate is not built on mandates but on SPAMing: I joined for
testing purposes half a year ago and have received 150 mails from
them meanwhile.<br>
<blockquote type="cite"><span
style="font-family:"Calibri","sans-serif";color:#1F497D">Does
it make money from something? Probably, but not from selling
articles. This is murky, as are many issues in OA.</span></blockquote>
I would not think that "commercial re-use" is limited to an outright
(re-)selling of articles. <br>
This "murky-ness" of the term, is key: As long as Peter is doing his
thing on research grants, the clause<br>
<blockquote type="cite">
<pre wrap="">provided non-commercial re-use such as text and data mining is supported</pre>
</blockquote>
may protect him. But what if he tried the obvious and recover some
money through premium services for, say, the pharmaceutical
industry? (He might be forced some time in the future to do so by
funds drying up our cost shooting through his institution's roof)<br>
<br>
best,<br>
<br>
Hans<br>
<br>
<br>
</body>
</html>